Boehringer Ingelheim

Ridgefield’s Boehringer Ingelheim makes $50M investment, hands off schizophrenia therapy commercialization

The investment is in Click Therapeutics, which co-developed an app-based treatment designed to help people with schizophrenia.

Boehringer, CT Science Center launch STEM lab in Hartford

The Connecticut Science Center and Boehringer Ingelheim have launched a new Innovation Lab aimed at expanding STEM education opportunities.

🔒 CT Invention Convention rebrands as NextMinds, expands nationally and globally

Connecticut Invention Convention rebrands as NextMinds and expands beyond state borders, serving 12,000 students in 300 schools with $775,000 backing from ASML.

Boehringer Ingelheim, with major CT presence, announces plans to invest $10B in U.S.

Boehringer, one of Connecticut’s largest pharmaceutical employers, has reached an agreement with the U.S. government to lower some drug costs and expand its U.S. operations.

- Advertisement -

Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.